GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akebia Therapeutics Inc (STU:AX9) » Definitions » Price-to-Tangible-Book

Akebia Therapeutics (STU:AX9) Price-to-Tangible-Book : (As of May. 17, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Akebia Therapeutics Price-to-Tangible-Book?

As of today (2025-05-17), Akebia Therapeutics's share price is €2.324. Akebia Therapeutics's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was €-0.12. Hence, Akebia Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Akebia Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Akebia Therapeutics's highest Price to Tangible Book Ratio was 22.72. The lowest was 1.98. And the median was 3.93.

STU:AX9's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.25
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Akebia Therapeutics's share price is €2.324. Akebia Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2025 was €0.09. Hence, Akebia Therapeutics's P/B Ratio of today is 26.71.


Akebia Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Akebia Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akebia Therapeutics Price-to-Tangible-Book Chart

Akebia Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.33 - - - -

Akebia Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Akebia Therapeutics's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Akebia Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akebia Therapeutics's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akebia Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Akebia Therapeutics's Price-to-Tangible-Book falls into.


;
;

Akebia Therapeutics Price-to-Tangible-Book Calculation

Akebia Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=2.324/-0.122
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Akebia Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Akebia Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Akebia Therapeutics Business Description

Traded in Other Exchanges
Address
245 First Street, Suite 1400, Cambridge, MA, USA, 02142
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Akebia Therapeutics Headlines

No Headlines